Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health

Joint Bone Spine

Volumn 80, Issue 6, 2013, Pages 574-581

  Goëb, Vincent ^a   Ardizzone, Marc ^b   Arnaud, Laurent ^c   Avouac, JérÔme ^d   Baillet, Athan ^e   Belot, Alexandre ^f   Bouvard, Béatrice ^g   Coquerelle, Pascal ^h   Dadoun, Sabrina ⁱ   Diguet, Alain ^j   Launay, David ^k   Lebouc, Danielle ^l   Loulergue, Pierre ^m   Mahy, Sophie ⁿ   Mestat, Pascal ^l   Mouterde, Gaël ^o   Terrier, Benjamin ^l   Varoquier, Coralie ^p   Verdet, Mathieu ^b   Puéchal, Xavier ^c   Sibilia, Jean ^q   more..

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b CH de Mulhouse   (France)

^c Service de Médecine Interne HÔpital Cochin AP HP   (France)

^d université Paris Cité   (France)

^e Service de Rhumatologie HÔpital Sud GREPI AGIM UJF CNRS FRE3405   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h Service de Néphrologie Rhumatologie Centre Hospitalier de Béthune   (France)

ⁱ Hospitalier Pitie Salpetriere   (France)

^j ROUEN UNIVERSITY HOSPITAL   (France)

^k UNIV LILLE   (France)

^l Service de Maladies Infectieuses HÔpital Cochin AP HP ^*  (France)

^m Service de Maladies Infectieuses HÔpital Cochin AP HP   (France)

ⁿ DIJON UNIVERSITY HOSPITAL   (France)

^o MONTPELLIER UNIVERSITY HOSPITAL   (France)

^p Service de Rhumatologie   (France)

^q UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Adalimumab; Cancer; Certolizumab; Etanercept; French National Authority for Health (HAS); Golimumab; Infection; Infliximab; Older patients; Paradoxical adverse events; Pregnancy; Recommendations; Surgery; TNF antagonist; Vaccination; Vasculitis

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEPATITIS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGING; ARTICLE; CANCER REGRESSION; DENTAL PROCEDURE; DRUG WITHDRAWAL; EMERGENCY SURGERY; ENTERITIS; FOLLOW UP; GENERAL PRACTITIONER; HEMATOLOGIC MALIGNANCY; HUMAN; INFLUENZA VACCINATION; LUPUS VULGARIS; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; NON MELANOMA SKIN CANCER; PATIENT MONITORING; PATIENT SAFETY; PRACTICE GUIDELINE; PREGNANCY; PSORIASIS; RHEUMATOID ARTHRITIS; RHEUMATOID VASCULITIS; RISK BENEFIT ANALYSIS; SARCOIDOSIS; SOLID TUMOR; UVEITIS; VACCINATION; ANTAGONISTS AND INHIBITORS; AUTOIMMUNE DISEASES; INFLAMMATORY BOWEL DISEASES;

ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888405902     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.09.001     Document Type: Article

References (0)